Code of Ethics

AdvaMed® Letter Regarding HCIC RFI on AKS Final Rule

AdvaMed® submitted feedback regarding safe harbor revisions under the federal Anti-Kickback Statute.

U.S. Department of Justice (DOJ) Business Review Letter – Healthcare Collaborations

AdvaMed® Letter: Clarification of Eligibility for Small Businesses with Equity Investors under the SBA’s 7(a) Loan Program within the CARES Act

Coalition Letter: Clarification of Eligibility for Small Businesses with Equity Investors under the SBA’s 7(a) Loan Program within the CARES Act

Global & Trade

Global Medical Technology Alliance: Open letter to the G-20 Heads of State and Government: Need to collaborate to open global trade in response to COVID-19

Regulatory Affairs

AdvaMed® Letter to FDA: Letter to Owen Faris RE Clinical Trials Flex Proposals

“Dear Governor” Letter from 8 national health care products trade groups

Legal / Value-Based Collaborations

May 8, 2019 AdvaMed® Letter Refining Value-Based Safe Harbor Proposals

Legal / Value-Based Collaborations

AdvaMed® Statement on Health Care Innovation Caucus RFI Regarding Value-Based Arrangements

Diagnostics / Regulatory Affairs

AdvaMedDx® Letter to Sen. Alexander and Murray and Rep. Walden and Pallone